Header Logo

Connection

Anthonet Koen to BCG Vaccine

Back to Details
This is a "connection" page, showing publications Anthonet Koen has written about BCG Vaccine.
Anthonet Koen
Connection Strength
0,051
BCG Vaccine
  1. Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial. Lancet Infect Dis. 2022 Oct; 22(10):1472-1483.
    View in: PubMed
    Score: 0,051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.